{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:46:18Z","timestamp":1775605578638,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejso.2025.110535","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:00:32Z","timestamp":1761433232000},"page":"110535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Number of affected lymph nodes predicts outcome in extremity rhabdomyosarcoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Luna","family":"Margotte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Henssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Thorwarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-6268","authenticated-orcid":false,"given":"Monika","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pbc.23252","article-title":"Soft tissue sarcoma across the age spectrum: a population-based study from the surveillance epidemiology and end results database","volume":"57","author":"Ferrari","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2025.110535_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30701","article-title":"Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on children's oncology group studies","volume":"70","author":"Schloemer","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib3","article-title":"Extremity Rhabdomyosarcoma-An integrated clinicopathologic and genomic study to improve risk stratification","volume":"7","author":"de Traux de Wardin","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110535_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/BF01655884","article-title":"Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors","volume":"12","author":"Lawrence","year":"1988","journal-title":"World J Surg"},{"issue":"23","key":"10.1016\/j.ejso.2025.110535_bib5","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1200\/JCO.2004.04.083","article-title":"European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors","volume":"22","author":"Carli","year":"2004","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2025.110535_bib6","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1200\/JCO.2007.14.7207","article-title":"Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups","volume":"26","author":"Oberlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110535_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00066-021-01780-7","article-title":"Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered","volume":"197","author":"Welmant","year":"2021","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib8","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1038\/s41598-020-62656-x","article-title":"Survival stratification in childhood rhabdomyosarcoma of the extremities: a derivation and validation study","volume":"10","author":"Zhu","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/mpo.2950180606","article-title":"Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma","volume":"18","author":"Mandell","year":"1990","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.4-1-34","article-title":"Rhabdomyosarcoma: an overview","volume":"4","author":"Dagher","year":"1999","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30293","article-title":"Rhabdomyosarcoma with isolated lung metastases: a report from the soft tissue sarcoma committee of the Children's oncology group","volume":"70","author":"Vasquez","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"10.1016\/j.ejso.2025.110535_bib12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.2011.38.5591","article-title":"PAX3\/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification","volume":"30","author":"Missiaglia","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2003.06.129","article-title":"Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the intergroup rhabdomyosarcoma study IV","volume":"21","author":"Breneman","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110535_bib14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The third intergroup rhabdomyosarcoma study","volume":"13","author":"Crist","year":"1995","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.ejso.2025.110535_bib15","article-title":"Rhabdomyosarcoma","volume":"68","author":"Yechieli","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2025.110535_bib16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/pbc.24532","article-title":"PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report","volume":"60","author":"Skapek","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"1 Suppl","key":"10.1016\/j.ejso.2025.110535_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W","article-title":"Childhood cancer","volume":"75","author":"Miller","year":"1995","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.ejso.2025.110535_bib18","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.ejso.2025.110535_bib19","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1200\/JCO.2005.05.3801","article-title":"Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children's oncology group","volume":"24","author":"Meza","year":"2006","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.ejso.2025.110535_bib20","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1200\/JCO.2012.44.6476","article-title":"Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the children's oncology group soft tissue sarcoma committee","volume":"31","author":"Weiss","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110535_bib21","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease","volume":"19","author":"Crist","year":"2001","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110535_bib22","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1200\/JCO.2005.08.130","article-title":"Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the international society of paediatric Oncology--SIOP malignant mesenchymal tumor 89","volume":"23","author":"Stevens","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110535_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2023.12.004","article-title":"Rhabdomyosarcoma: updates on classification and the necessity of molecular testing beyond immunohistochemistry","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"issue":"20","key":"10.1016\/j.ejso.2025.110535_bib24","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1002\/cam4.3365","article-title":"Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study","volume":"9","author":"Terwisscha van Scheltinga","year":"2020","journal-title":"Cancer Med"},{"issue":"20","key":"10.1016\/j.ejso.2025.110535_bib25","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2011.40.3287","volume":"30","author":"Oberlin","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110535_bib26","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/pbc.25684","article-title":"Prognostic factors for outcome in localized extremity rhabdomyosarcoma. Pooled analysis from four international cooperative groups","volume":"62","author":"Oberlin","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2025.110535_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28608","article-title":"Surgical management of extremity rhabdomyosarcoma: a consensus opinion from the Children's oncology group, the european pediatric soft-tissue sarcoma study group, and the cooperative weichteilsarkom studiengruppe","volume":"70","author":"Morris","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.110535_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L","article-title":"The intergroup rhabdomyosarcoma Study-I. A final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib29","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/pbc.23292","article-title":"Long-term results in childhood rhabdomyosarcoma: a report from the Italian cooperative study RMS 79","volume":"58","author":"Bisogno","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2025.110535_bib30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1200\/JCO.2007.15.0466","article-title":"Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults","volume":"27","author":"Dantonello","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19820101)49:1<1::AID-CNCR2820490102>3.0.CO;2-Q","article-title":"Extremity lesions in the intergroup rhabdomyosarcoma study (IRS-I): a preliminary report","volume":"49","author":"Hays","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2025.110535_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153558","article-title":"Immunohistochemical expression of cyclin-dependent kinase inhibitors p16 and p57 in rhabdomyosarcoma","volume":"225","author":"Glumac","year":"2021","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.ejso.2025.110535_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29511","article-title":"An update on rhabdomyosarcoma risk stratification and the rationale for current and future children's oncology group clinical trials","volume":"69","author":"Haduong","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"10.1016\/j.ejso.2025.110535_bib34","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1002\/cam4.2504","article-title":"Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the children's oncology group","volume":"8","author":"Hibbitts","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2025.110535_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jss.2021.01.005","article-title":"A population-based analysis of lymph node metastasis in extremity soft tissue sarcoma: an update","volume":"262","author":"Gusho","year":"2021","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.ejso.2025.110535_bib36","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/jso.26465","article-title":"Pathologic nodal staging for clinically node negative soft tissue sarcoma of the extremities","volume":"123","author":"Maduekwe","year":"2021","journal-title":"J Surg Oncol"},{"issue":"282","key":"10.1016\/j.ejso.2025.110535_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"10.1016\/j.ejso.2025.110535_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mpo.2950200305","article-title":"Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis","volume":"20","author":"Koscielniak","year":"1992","journal-title":"Med Pediatr Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110535_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35929","article-title":"Extremity rhabdomyosarcoma in children, adolescents and young adults: a report from children's oncology group trials","volume":"131","author":"Oberoi","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1200\/JCO.1988.6.1.67","article-title":"Histopathology of childhood sarcomas, intergroup rhabdomyosarcoma studies I and II: clinicopathologic correlation","volume":"6","author":"Newton","year":"1988","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110535_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28832","article-title":"Alveolar rhabdomyosarcoma with regional nodal involvement: results of a combined analysis from two cooperative groups","volume":"68","author":"Gallego","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2025.110535_bib42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2010.29.4611","article-title":"Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the children's oncology group","volume":"29","author":"Rodeberg","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110535_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31538","article-title":"Lymph node staging and treatment in pediatric patients with soft tissue sarcomas: a consensus opinion from the children's oncology group, European paediatric soft tissue sarcoma study group, and the cooperative weichteilsarkom studiengruppe","volume":"72","author":"Terwisscha van Scheltinga","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2025.110535_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archsurg.2009.210","article-title":"Colon cancer and low lymph node count: who is to blame?","volume":"144","author":"Jakub","year":"2009","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.110535_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1245\/s10434-024-16391-6","article-title":"How many lymph nodes are enough in thyroidectomy? A cohort study based on real-world data","volume":"32","author":"Wei","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110535_bib46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1245\/s10434-021-10947-6","article-title":"Too many or too few? How many lymph nodes are enough?","volume":"29","author":"Sachs","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib47","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1038\/s41598-024-59757-2","article-title":"Number of positive lymph nodes affects oncologic outcomes in cN0 mucoepidermoid carcinoma of the major salivary gland","volume":"14","author":"Chang","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/annonc\/mdt510","article-title":"The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis","volume":"25","author":"Rossi","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1245\/ASO.2003.03.058","article-title":"The prognosis of T3N0 Colon cancer is dependent on the number of lymph nodes examined","volume":"10","author":"Swanson","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110535_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3468(00)90031-9","article-title":"Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the intergroup rhabdomyosarcoma study IV (1991-1997)","volume":"35","author":"Neville","year":"2000","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.ejso.2025.110535_bib51","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2010.03.050","article-title":"Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the children's oncology group","volume":"80","author":"La","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejso.2025.110535_bib52","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpedsurg.2016.08.024","article-title":"Quality assessment of lymph node sampling in rhabdomyosarcoma: a surveillance, epidemiology, and end results (SEER) program study","volume":"52","author":"Lobeck","year":"2017","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00148581-200709060-00006","article-title":"Optimal management strategies for rhabdomyosarcoma in children","volume":"9","author":"Walterhouse","year":"2007","journal-title":"Paediatr Drugs"},{"issue":"11","key":"10.1016\/j.ejso.2025.110535_bib54","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/ijc.33143","article-title":"Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: a report from the children's oncology group soft tissue sarcoma committee","volume":"147","author":"Routh","year":"2020","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2025.110535_bib55","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S1470-2045(19)30617-5","article-title":"Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Bisogno","year":"2019","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib56","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1200\/OP.21.00223","article-title":"Closing the gaps: progress in the care of adolescents and young adults with cancer","volume":"17","author":"Ketterl","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"10.1016\/j.ejso.2025.110535_bib57","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10.1016\/j.ejso.2025.110535_bib58","doi-asserted-by":"crossref","first-page":"17051","DOI":"10.1007\/s00432-023-05350-5","article-title":"Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry","volume":"149","author":"M\u00fcller","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2025.110535_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70348","article-title":"The other site of rhabdomyosarcoma","volume":"13","author":"Kern","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2025.110535_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107263","article-title":"Rhabdomyosarcoma of head and neck varies in aggressiveness depending on the specific site of origin","volume":"164","author":"Rohde","year":"2025","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110535_bib61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cam4.1802","article-title":"Marital status and survival in patients with soft tissue sarcoma: a population-based, propensity-matched study","volume":"8","author":"Zhang","year":"2019","journal-title":"Cancer Med"},{"issue":"27","key":"10.1016\/j.ejso.2025.110535_bib62","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1200\/JCO.2018.77.9694","article-title":"Addition of vincristine and Irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the children's oncology group","volume":"36","author":"Hawkins","year":"2018","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110535_bib63","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1470-2045(24)00255-9","article-title":"Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the children's oncology group","volume":"25","author":"Gupta","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejso.2017.09.015","article-title":"Treatment challenges in and outside a network setting: soft tissue sarcomas","volume":"45","author":"Pasquali","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejso.2017.12.012","article-title":"Centers of excellence or excellence networks: the surgical challenge and quality issues in rare cancers","volume":"45","author":"Sandrucci","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110535_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2018.09.003","article-title":"Histopathologic challenges: the second OPINION issue","volume":"45","author":"Lopez-Beltran","year":"2019","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:52:14Z","timestamp":1775602334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0748798325009631"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110535","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Number of affected lymph nodes predicts outcome in extremity rhabdomyosarcoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110535"}}